Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)

NCT04085458 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Damoctocog alfa pegol (Jivi, BAY94-9027)

Sponsor

Bayer